The antibodies don’t work! The race to rid labs of molecules that ruin experiments
Nature – Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
Nature – Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
Nature – The treatment, given to four people with damaged corneas, seems safe but needs to be tested in larger trials.
The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell…
The convenience, affordability, and flat-out fun of e-bikes and e-scooters are undeniable. But as their popularity grows, the rate of accidents involving e-bikes and e-scooters…
The 1976 Medical Device Amendments granted the US Food and Drug Administration (FDA) regulatory authority over medical devices. The FDA’s regulatory review requirements are intended…
This physician-scientist’s discovery could help stop or slow damage to kidneys Ahmed Ahmed blends public policy with medicine to learn about the healthcare workforce. Read…
A psychologist explains what attention-seeking behavior is, its many causes and how to stop it.
New York City is ending its controversial scheme that gave migrant families prepaid debit cards that gave migrant families a total of $18,500 each.
Experiential evidence must be open to scrutiny and criticism The literature on development of clinical guidelines generally accepts that patients and carers should be involved…
Dozens of rhesus macaques escaped a research facility in South Carolina. They’re still on the lam.
Increasing demand in Alberta for diagnostic imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) scans means more appointments are being made months…